drugset / Trial / NCT00457769

Aricept to Improve Functional Tasks in Vascular Dementia

NCT00457769

Phase 1 Unknown 18 enrolled Kessler Foundation Pfizer · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

Medications for memory improvement are available but they may not actually improve the ability to do real world tasks. The purpose of this research study is to determine if a medicine used to treat memory problems donepezil(Aricept) enhances the ability to remember steps of functional tasks and the actual ability to perform tasks relevant to real-life independence. Aricept is an FDA approved medication for the treatment of Alzheimer's disease. Aricept is an investigational drug for the purposes of this study, and is not approved for this purpose.

Timeline

Start
2007-05
Primary completion
2021-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg Oral